Senior Consultant Physician
Sydney South West Area Health Service
University of Western Sydney
Section Chief of Nephrology,
University of New Mexico
COI: Consultant fees (Bayer, Otsuka, Quanta)
Patent: Protocols for RNA sequencing (non COVID)
I am a UK-trained GP/family practitioner, and since 2013 an emergency doctor in some of the remotest parts of Australia. I was a BMA-appointed non-executive director on the main board of the BMJ Group Ltd in London from 2009 to 2018. I have been a pilot since I was seventeen and frequently draw on risk experience from aviation to inform decisions in medicine and public health. I’ve published a fair few articles since 2020. The two I’d most like you to read are these:
2021 September Underlying health conditions? That’s almost all of us Sydney Morning Herald / The Age
2021 January Up the line to death: covid-19 has revealed a mortal betrayal of the world’s healthcare workers BMJ Opinion.
Conflict of Interest: In early 2021, I started a company that sells indoor CO2 detectors online in Australia and, more recently, N95 respirators.
Professor Brendan Crabb is an infectious disease researcher with experience in virology and parasitology, especially malaria. Since 2008 he has been the Director and CEO of the Burnet Institute, a research institute with a vision of a ‘more equitable world through better health’. In honorary capacities, Prof Crabb is a past-President of the peak body for medical research institutes in Australia (the Australian Association of Medical Research Institutes); and is currently President of the global health peak bodies the Australian Global Health Alliance and the Pacific Friends of Global Health. He also serves on the board of the Telethon Kids Institute. He is a Fellow of the Australian Academy of Science (FAA) and a Fellow of the Australian Academy of Health, and Medical Sciences (FAHMS). He served on the governing Council of the National Health and Medical Research Council (NHMRC) of Australia from 2016 – 2021, and on the National COVID Health Research Advisory Committee in 2020-21. He currently serves on the advisory boards of the Sanger Institute in the UK, and on the WHO Malaria Vaccine Advisory Committee (MALVAC). Professor Crabb was the Co-Founder of the 1st Malaria World Congress. He is a member of OzSAGE.
I am a Professor of Chemistry and Molecular Biology at the University of Gothenburg specialising in understanding the basis for communication between brain cells, and an elected member of the Swedish Academy of Science. I have been active in Vetenskaps Forum in Sweden, have cosigned/authored articles in Swedish, Norwegian, French and American periodicals including TIME, was a member of the team for the Delphi Consensus paper on COVID19 in Nature as well as a paper in Humanities and Social Sciences Communications. I have focussed attention on the importance of mass action via massive infection numbers on mutation rate and the effect of SARS2 infection on the brain.
Dr. Malgorzata (Gosia) Gasperowicz is a developmental biologist with background in biophysics currently affiliated with the University of Calgary. She earned her Masters at the Intercollegiate Faculty of Biotechnology in Gdansk, Poland, and a PhD in biology at Albert Ludvig University of Freiburg, Germany.
Dr. Gasperowicz is a co-founder of ZeroCOVIDCanada.org, which advocated for applying elimination strategy to stop the threat posed by SARS-CoV-2. She is a member of COVIDisAirborne, Canadian Aerosol Transmission Coalition, ProtectOurProvinceAlberta, and was a member of the former Strategic COVID-19 Pandemic Committee of the Edmonton Zone Medical Staff Association (EZMSA).
Since the beginning of the pandemic, Dr. Gasperowicz has been analyzing the dynamics of SARS-CoV-2 spread, correctly predicting policies’ outcomes, and communicating this scientific understanding via social and traditional media. She advocates for better pandemic-response policies.
I am an author and screenwriter. Prior to becoming a full-time writer, I was a strategy consultant for some of the world’s leading medical and pharmaceutical companies. In February 2020, I was asked to provide external analysis of the risks of a coronavirus pandemic to the UK Health Secretary, and highlighted two issues with the so-called herd immunity strategy: long-term sequelae and reinfection. I subsequently led a number of public health initiatives and have co-authored papers on COVID-19, including one on the long term risks of infection. No conflicts.
I am a public health physician and epidemiologist working in infectious diseases research at the University of New South Wales in Sydney, Australia. My areas of research are vaccinology, face masks and prevention of epidemic and pandemic infections. Full biography.
Research Scientist, Department of Genetics, School of Medicine, Stanford University.
I am a basic researcher in the field of genomics. I started the pandemic with the naive expectation that it would be handled the same way as SARS1 back in 2003, but then in late March 2020 it became clear, to my great horror, that “herd immunity” will be what governments will go for instead. Since then I have been writing scientific articles analysing the development and the impact of the pandemic, writing popular articles and giving interviews explaining its scientific aspects (the lack of lasting immunity and reinfections, long-term sequelae, etc.) and the socioeconomic factors that determined the path chosen for us, and in general battling the rampant propaganda and disinformation aimed at making SARS endemic.
I am a lawyer and patent/trademark agent. I've worked across a wide variety of areas of law including some which involve a very detailed and deep knowledge of science such as patent pharmaceutical litigation. In February 2020 as the pandemic hit, I wanted to know something about coronaviruses and pulled old review articles which told me all I needed to know. I discovered that the notion of droplet transmission was nonsense, and started advising people that respiratory illnesses travel through the air and we ought to use air mitigations to reduce cases. I co-founded COVID Is Airborne in mid 2020 with a bunch of like-minded volunteers. Just for speaking out about things we should be doing to make this pandemic safer for everyone, and that frankly I think we're going to have to get around to doing at some point anyway, I have been published three times in major scientific publications. Yet we are still not mitigating and we can do better.
Lidia Morawska is Distinguished Professor at the Queensland University of Technology in Brisbane, Australia, and the Director of the International Laboratory for Air Quality and Health at QUT, which is a Collaborating Centre of the WHO. Lidia also holds positions of Vice-Chancellor Fellow, Global Centre for Clean Air Research (GCARE), University of Surrey, UK. She conducts fundamental and applied research in the interdisciplinary field of air quality and its impact on human health and the environment, with a specific focus on science of airborne particulate matter. She is a physicist and received her doctorate at the Jagiellonian University, Krakow, Poland for research on radon and its progeny. An author of close to one thousand journal papers, book chapters and refereed conference papers, Lidia has been involved at the executive level with several relevant national and international professional bodies, is a fellow of the Australian Academy of Science and a recipient of numerous scientific awards. She was named one of TIME100 world’s most influential people for 2021, for her global leadership work on the importance of airborne transmission of SARS-CoV-2.
I am an emergency physician practicing in academic and community hospitals in Toronto, Canada. I have academic ties to the University of Toronto and McMaster University. I have some computer science experience and am a startup founder of the Raven CleanAir Map, which is supported by a grant from the Balvi Philanthropic Fund, and is a mapping and news website that helps fight misinformation, as well as helps find indoor locations with good ventilation. I often engage in public work as a science communicator with hundreds of appearances on the BBC, CBC, CTV, CBC radio and local news outlets throughout the pandemic.
I am a microbiologist and President/Chief Scientific Officer of PolyBio Research Foundation - a research non-profit studying the chronic consequences of acute viral, bacterial, and fungal infection. We conceptualize and coordinate large-scale collaborative research projects among scientific teams studying infection-associated chronic illnesses such as LongCovid, ME/CFS and LongLyme. In that capacity I direct PolyBio's LongCovid Research Consortium (LCRC): a scientific collaboration to rapidly and comprehensively study LongCovid, with a focus on the persistence of the SARS-CoV-2 virus in tissue. I strongly believe that solutions for LongCovid must run in parallel with efforts to clean the air. Only by that dual approach can we truly expect to curb or eliminate the acute and chronic consequences of SARS-CoV-2.
Dr Michelle Scoullar is a General Paediatrician with broad clinical experience in tertiary, community, rural and remote settings in Victoria, NSW, Queensland, Lao People’s Democratic Republic (PDR) and Papua New Guinea (PNG). She is passionate about patient centred, culturally sensitive, quality care that upholds patient voice, dignity and an ability-based approach. Michelle is also an international health specialist, having complemented her clinical training with a Masters of International Health and has led operational and implementation research, health system strengthening, and health worker training in maternal, newborn and child health in PNG, Lao PDR and Myanmar. Her most significant contribution in this work has been as a Principal Investigator on Burnet Institute’s flagship Healthy Mothers, Healthy Babies (HMHB) program based in East New Britain (ENB), PNG. Michelle established the HMHB field site which included the cementing of all key partnerships, the establishment of a physical office, the building of a research laboratory and the hiring, training, and management of an administrative and technical research team. She also managed the successful completion of a large longitudinal cohort study, the first of its kind in PNG, following women and their infant from early pregnancy through to twelve months postpartum.
Michelle is the paediatrician at Clinic Nineteen, a telehealth practice caring for people with Long COVID, she has worked at Burnet Institute as a Senior Research Officer since 2014, and is completing her PhD, focused on nutrition and infections in pregnancy, and their impact on birth weight.
Joe Vipond has worked as an emergency physician for over twenty years, currently at the Rockyview General Hospital. He has been active on the climate crisis since learning of its repercussions 15 years ago . His first advocacy campaign was as a spokesperson and strategist for the Alberta Coal Phase Out movement, and the Canadian Coal Phase Out network, and with these has had an impact on approximately 66 MT of greenhouse gas emissions, or 9% of Canada's total GHGs. He is Past-President of the national charity Canadian Association of Physicians for the Environment. He is also the co-founder and board member of the local non-profit the Calgary Climate Hub, and during COVID, the co-founder of #masks4Canada and ProtectOurProvinceAB. Joe grew up in Calgary and continues to live there with his wife and two daughters.
Dr. Dick Zoutman is Emeritus Professor, in the Faculty of Health Sciences, School of Medicine at Queen's University. Dr. Zoutman is the Past Inaugural Chief of Staff at the Scarborough Health Network in Toronto and Past Chief of Staff at Quinte Health in South Eastern Ontario.
He is a Fellow of the Royal College of Physicians of Canada, specializing in Internal Medicine, Infectious Diseases, and Medical Microbiology. He is also the Past Professor and Chair of Infectious Diseases and of Medical Microbiology at the Kingston Health Sciences Center and Queen’s University.
The primary focus of his academic research has been on the use of Quality Improvement Science in advancing healthcare quality and infectious diseases. Dr. Zoutman has worked and studied internationally across 6 continents.
During the 2003 pandemic of SARS1 Dr. Zoutman chaired the Ontario SARS Scientific Advisory Committee responsible for advising the Ontario Government on the management of the pandemic.
In the aftermath of SARS1 Dr. Zoutman was appointed as the founding Co-Chair of the Ontario Provincial Infectious Diseases Advisory Committee (PIDAC) that established province-wide best practices in Infectious Diseases prevention.
Dr. Zoutman was appointed as a Fellow of the Center for the Study of Democracy and has a Black Belt in Lean and Six Sigma for Healthcare. He is a Canadian Certified Physician Executive and a Chartered Director with the Conference Board of Canada and the De Groote School of Business.